Category: SCIENCE

Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial
Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial Results of the treatment Contact Us Summary Patients with Ovarian cancer (OvCa) were treated with autologous dendritic cells (DCs) and IL-2 to evaluate the safety and feasibility of this therapeutic strategy and to characterize the antigen-specific immune alterations […]

Ilixadencel (allogeneic dendritic cells) : A Promising Treatment For GIST (advanced gastrointestinal stromal tumor)
Ilixadencel (allogeneic dendritic cells) : A Promising Treatment For GIST (advanced gastrointestinal stromal tumor) Advanced gastrointestinal stromal tumor Contact Us Summary Gastrointestinal stromal tumor (GIST) is most frequently located in the stomach or small intestine. Subsequent treatments have limited efficacy for patients with advanced GIST. Ilixadencel (allogeneic inflammatory dendritic cells) Treatment presented an acceptable safety […]

Improve Survival in Cancer Patients with Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy and Cytokine Induced Killer Cells
Improve Survival in Cancer Patients with Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy and Cytokine Induced Killer Cells Time to be disease free Contact Us Summary Gastric and colorectal cancers (GC and CRC) are resistant to chemo- and/or radiotherapy Dendiritc Cell immunotherapy combined with cytokine-induced killer (CIK) reduced the risk of post-operative disease progression with an […]

Dendritic cell therapy in cancer treatment; the state-of-the-art
Dendritic cell therapy in cancer treatment; the state-of-the-art DC vaccines in detail Contact Us Summary Dendritic Cell Immunotherapy is a new alternative for cancer treatment. DC is obtained from the patient and modulated in other to boost the immune system toward tumour elimination. Several approaches have been on the evaluation for long-term anti-tumor immune responses […]

Cancer Vaccines: Powerful Tool in Cancer Immunotherapy of breast cancer
Cancer Vaccines: Powerful Tool in Cancer Immunotherapy of breast cancer Dendritic Cell Activity Contact Us Summary Cancer vaccine is widely considered as a powerful tool in immunotherapy. In this trial, a versatile cancer cell membrane (CCM) coated calcium carbonate (CC) nanoparticles (MC) that capable of generating in situ tumor-associated antigens (TAAs) for DC vaccination is […]

Cytolytic Immunity of CIK cells upon Coculture with Mature Dendritic Cells
Cytolytic Immunity of CIK cells upon Coculture with Mature Dendritic Cells Results of the treatment Contact Us Summary Dendritic cells (DCs) are considered the most potent professional antigen-presenting cells (APCs) that elicit adaptive antitumour immunity. In this study several methods of boosting DC-based vaccines are discussed and a review of the current knowledge of contact-dependent […]

Substantial remission of Prostate Adenocarcinoma with Dendritic Cell Therapy APCEDEN® in combination with Chemotherapy
Substantial remission of Prostate Adenocarcinoma with Dendritic Cell Therapy APCEDEN® in combination with Chemotherapy Contact Us Summary Prostate adenocarcinoma is the most common cancer and second leading cause of cancer-related death in men. This case study describes the substantial remission of advanced prostate cancer after receiving a personalized dendritic cell therapy in combination with the […]

Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report
Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report Brain scans Contact Us Introduction content missing Methodology content missing Therapy content missing Results content missing Conclusion content missing Article Reference link: click here Scientific article publishing date: 23/3/2017 Immucura identifier: BSC21_017EN Contact Us SEARCH

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma MGMT Methylated Contact Us Summary This trial aims to evaluate the addition of an autologous tumor lysate-pulsed Dendritic Cell vaccine (DCVax®-L) to standard therapy for patients diagnosed with glioblastoma. The findings suggest the addition […]

Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report
Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report Dendritic Cells attacking tumour cells Contact Us Summary Despite adjuvant chemotherapy and radiotherapy, recurrence or metastasis rates after curative resection of rectal cancer are up to 60% depending on the stage of the tumour. In […]